HOME >> BIOLOGY >> NEWS
Proteomics and alcoholism research

"Proteomics" refers to the study of proteins that are synthesized by cells, tissues and organs in the body. Recent advances in technology now allow scientists to separate and identify these proteins. According to symposium proceedings published in the February issue of Alcoholism: Clinical & Experimental Research, proteomics has important implications for alcoholism research in terms of identifying biomarkers of alcohol intake, understanding alcohol's effects, particularly on the liver, and developing drugs to treat alcoholism.

"The study of proteins involved in alcoholism has taken two different approaches," said Chinnaswamy Kasinathan, associate professor at the University of Medicine and Dentistry of New Jersey and symposium organizer. "One approach is to select a protein for study because of its role in a pathway believed to involve alcoholism. Since alcoholism is a behavioral disorder, many of the candidate proteins selected for study are involved in neurochemical pathways. An alternate proteomic approach is to study as many proteins as can be separated by a technique such as 2D gel electrophoresis and identified through mass spectrometry. This approach does not select any candidate protein in advance, rather, this approach incorporates and examines the entire proteosome of the body."

The symposium took place at the June 2003 Research Society on Alcoholism meeting in Fort Lauderdale, Florida. Some of the key points were:

  • Research designed to identify a urinary biomarker for alcohol intake has found the presence of two groups of proteins in the urine of alcohol-treated rats but not in the urine of control animals.

    "The ultimate goal of this research is to apply the animal findings to the development of good urinary biomarkers in humans as a measure of alcohol intake," said Kasinathan.

    "This would have important applications for many alcoholism treatment facilities," he added. "For example, there are a
    '"/>




  • 15-Feb-2004


    Page: 1 2 3

    Related biology news :

    1. Proteomics drives new generation of medical treatment
    2. Consortium for Archaeal Genomics and Proteomics established at Penn State
    3. A liking for sweets, combined with novelty seeking, may predict alcoholism
    4. Acamprosate: potential medication for treating alcoholism
    5. Gene linked to alcoholism
    6. Gene therapy reduces drinking in rats with genetic predisposition to alcoholism
    7. A sweet tooth may be a marker for the genetic risk for developing alcoholism
    8. Adult alcoholism and attention-deficit hyperactivity disorder are connected
    9. Researchers find three chromosomal areas with links to alcoholism vulnerability
    10. The eyes have it: Seeking expressions of the genetic risk for developing alcoholism
    11. Investigating a protective gene against alcoholism

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    TAG: Proteomics and alcoholism research

    (Date:4/17/2014)... hundred births, Down syndrome - or trisomy 21 - ... It results from a chromosomal abnormality where cells of ... (1% of the human genome). A study conducted by ... Genetic Medicine and Development at the University of Geneva ... shed light on how the extra chromosome 21 upsets ...
    (Date:4/17/2014)... Rajendra Singh Thursday as a "Champion of Change" ... deployment in the residential, commercial and industrial sectors. ... Electrical and Computer Engineering and director of Clemson,s ... hero leading the charge across the country to ... and driving policy changes at the local level ...
    (Date:4/17/2014)... channels are implicated in many serious conditions such as ... potential target for drug therapies. Unfortunately, there is still ... Cambridge research provides fresh and unexpected insight into the ... components - β-subunit molecules - which are responsible for ... published in the most recent edition of the ...
    Breaking Biology News(10 mins):Trisomy 21: How an extra little chromosome throws the entire genome off balance 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 3White House honors Clemson professor as 'Champion of Change' for solar deployment 2Structure of sodium channels different than previously believed 2
    (Date:1/15/2014)... Toronto, Canada (PRWEB) January 15, 2014 ... perspectives on nonclinical and clinical safety assessment in biosimilars. ... a path for biosimilar drug development, however the complex ... regards to quality, safety and efficacy extremely challenging. Based ...
    (Date:1/15/2014)... 2014 Two champions of science, technology, ... of an annual competition for middle and high school ... innovative STEM study. The competition presents students with real-world ... Engineering Aptitude, Mathematics, and Sciences is a program ...
    (Date:1/15/2014)... 2013 was a banner year of continued ... saw continued independent research led by the team at ... $1 million grant from the Susanne Marcus Collins Foundation, ... peer reviewed journal, Amy Grant highlighted Brainwave Optimization® in ...
    (Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
    Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
    Cached News: